References of "2010"
     in
Bookmark and Share    
Full Text
See detailLes cultes isiaques à Emporion
Puccio, Laetizia ULg

in Pallas : Revue d'Etudes Antiques (2010), 84

This article presents a new interpretation of the temple M's content placed in the so-called sanctuary of Asklepios in Emporion. The sculptures are related to an inscription of the area and also to a ... [more ▼]

This article presents a new interpretation of the temple M's content placed in the so-called sanctuary of Asklepios in Emporion. The sculptures are related to an inscription of the area and also to a sigilado glass and chandeliers that come from the Roman city. All this proves the presence of an Egyptian worship in Emporion more complex than earlier. [less ▲]

Detailed reference viewed: 82 (8 ULg)
Full Text
See detailSemi-solid metallic alloys modeling for the simulation of thixoforming processes
Koeune, Roxane ULg; Ponthot, Jean-Philippe ULg

in Vaz Jr., M.; de Souza Neto, E. A.; Munoz-Rojas, P. A. (Eds.) Computational Materials Modeling (2010)

Detailed reference viewed: 47 (16 ULg)
Full Text
Peer Reviewed
See detailNatural functions of cyclic lipopeptides from Bacillus and Pseudomonas: more than surfactants and antibiotics
Raaijmakers, Jos; De Bruin, Irene; Nybroe, Ole et al

in FEMS Microbiology Reviews (2010), 34

Detailed reference viewed: 87 (12 ULg)
Full Text
See detailLa nouvelle économie sociale et solidaire : une repolitisation du quotidien ?
Frère, Bruno ULg

Article for general public (2010)

Detailed reference viewed: 31 (0 ULg)
Full Text
Peer Reviewed
See detailCotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron, Frédéric ULg; Lechanteur, Chantal ULg; Willems, Evelyne ULg et al

in Biology of Blood & Marrow Transplantation (2010), 16(6), 838-47

Recent studies have suggested that coinfusion of mesenchymal stem cells (MSCs) the day of hematopoietic cell transplantation (HCT) might promote engraftment and prevent graft-versus-host disease (GVHD ... [more ▼]

Recent studies have suggested that coinfusion of mesenchymal stem cells (MSCs) the day of hematopoietic cell transplantation (HCT) might promote engraftment and prevent graft-versus-host disease (GVHD) after myeloablative allogeneic HCT. This prompted us to investigate in a pilot study whether MSC infusion before HCT could allow nonmyeloablative (NMA) HCT (a transplant strategy based nearly exclusively on graft-versus-tumor effects for tumor eradication) from HLA-mismatched donors to be performed safely. Twenty patients with hematologic malignancies were given MSCs from third party unrelated donors 30-120 minutes before peripheral blood stem cells (PBSCs) from HLA-mismatched unrelated donors, after conditioning with 2 Gy total body irradiation (TBI) and fludarabine. The primary endpoint was safety, defined as a 100-day incidence of nonrelapse mortality (NRM) <35%. One patient had primary graft rejection, whereas the remaining 19 patients had sustained engraftment. The 100-day cumulative incidence of grade II-IV acute GVHD (aGVHD) was 35%, whereas 65% of the patients experienced moderate/severe chronic GVHD (cGVHD). One-year NRM (10%), relapse (30%), overall survival (OS) (80%) and progression-free survival (PFS) (60%), and 1-year incidence of death from GVHD or infection with GVHD (10%) were encouraging. These figures compare favorably with those observed in a historic group of 16 patients given HLA-mismatched PBSCs (but no MSCs) after NMA conditioning, which had a 1-year incidence of NRM of 37% (P = .02), a 1-year incidence of relapse of 25% (NS), a 1-year OS and PFS of 44% (P = .02), and 38% (P = .1), respectively, and a 1-year rate of death from GVHD or infection with GVHD of 31% (P = .04). In conclusion, our data suggest that HLA-mismatched NMA HCT with MSC coinfusion appeared to be safe. [less ▲]

Detailed reference viewed: 70 (32 ULg)
Full Text
Peer Reviewed
See detailSurgical Pleth Index to assess the anti-nociceptive component of general anaesthesia: Comparison with haemodynamic parameters and identification of confounding factors: 3AP3--3
HANS, Grégory ULg; Bonhomme, V.; Maquoi, I. et al

in European Journal of Anaesthesiology (2010), 27(47), 50

Detailed reference viewed: 12 (3 ULg)
Full Text
Peer Reviewed
See detailEffect of intravenous infusion of lidocaine on spontaneous recovery from cisatracurium-induced neuromuscular block: Preliminary results: 9AP4--3
HANS, Grégory ULg; Defresne, A.; Ki, B. et al

in European Journal of Anaesthesiology (2010), 27(47), 149

Detailed reference viewed: 7 (2 ULg)
Full Text
Peer Reviewed
See detailNovel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.
Rodriguez, Maria Margarita; Power, Pablo; Sader, Helio et al

in Antimicrobial agents and chemotherapy (2010), 54(7), 3070-1

Detailed reference viewed: 9 (0 ULg)
Full Text
Peer Reviewed
See detailNovel peptide inhibiting both TEM-1 beta-lactamase and penicillin-binding proteins.
Phichith, Denis; Bun, Sylvie; Padiolleau-Lefevre, Severine et al

in The FEBS journal (2010), 277(23), 4965-72

9G4H9, a catalytic antibody displaying beta-lactamase-like activity, has been developed by the anti-idiotypic approach using beta-lactamase as the first antigen. Thus 9G4H9 represents the 'internal image ... [more ▼]

9G4H9, a catalytic antibody displaying beta-lactamase-like activity, has been developed by the anti-idiotypic approach using beta-lactamase as the first antigen. Thus 9G4H9 represents the 'internal image' of beta-lactamase. We selected a cyclic peptide anchored to a bacteriophage M13 library using 9G4H9 as the target. Pep90 is a cyclic heptapeptide enclosed between two cysteine residues. We showed that Pep90 could inhibit both TEM-1 beta-lactamase (K(i) = 333 mum) and several penicillin-binding proteins (IC(5)(0) values ranging from 6-62 mum). We determined that the tryptophan residue of Pep90 is of crucial importance for its inhibitory activity. Using Pep90 as a scaffold, we generated a new class of peptidomimetics that retained inhibitory activity towards TEM-1 beta-lactamase. [less ▲]

Detailed reference viewed: 32 (0 ULg)
Full Text
Peer Reviewed
See detailQui dispose des dispositifs de médiation ?
Servais, Christine ULg

in Questions de Communication (2010), 10

Detailed reference viewed: 277 (77 ULg)
Full Text
Peer Reviewed
See detailBiotechnological applications of psychrophiles
Margesin, R.; Feller, Georges ULg

in Environmental Technology (2010), 31

Detailed reference viewed: 217 (13 ULg)
Full Text
Peer Reviewed
See detailInfluence of veneer thickness on residual stresses in zirconia prostheses.
Mainjot, Amélie ULg; Schajer, Gary; Vanheusden, Alain ULg et al

in Dental Materials (2010)

Detailed reference viewed: 45 (3 ULg)
Full Text
See detailL’édition pour la jeunesse en Belgique francophone : de la nécessité faite vertu à la mondialisation
Habrand, Tanguy ULg

in Pinhas, Luc; Foucault, Jean; Manson, Michel (Eds.) L'édition de jeunesse francophone face à la mondialisation (2010)

Detailed reference viewed: 39 (4 ULg)
Full Text
Peer Reviewed
See detailA new type of cubic-stacked layer structure in anthoinite, AlWO3(OH3)
Grey, I.; Madsen, I.; Mills et al

in American Mineralogist (2010), 95

Detailed reference viewed: 13 (0 ULg)
Full Text
See detailPierre Alechinsky. Récit d’un itinéraire pictural
Bawin, Julie ULg

in Culture, le Magazine Culturel de l'Université de Liège (2010)

Detailed reference viewed: 22 (3 ULg)
Full Text
Peer Reviewed
See detailApproche multirisque du patient diabetique de type 2: desaccord sur les valeurs cibles suite a l'etude ACCORD.
Scheen, André ULg; Paquot, Nicolas ULg

in Revue Médicale Suisse (2010), 6(260), 1582-7

The ACCORD trial investigated the effects of intensifying the global management of 10,251 type 2 diabetic patients, with established cardiovascular disease or at least two other cardiovascular risk ... [more ▼]

The ACCORD trial investigated the effects of intensifying the global management of 10,251 type 2 diabetic patients, with established cardiovascular disease or at least two other cardiovascular risk factors, on a composite endpoint (non fatal myocardial infarction, stroke and cardiovascular death). The attempt to reduce HbA1c level below 6% was associated with an increased cardiovascular mortality (despite a reduction in non fatal myocardial infarcts); lowering systolic blood pressure below 120 mmHg instead of 140 mmHg did not provide any additional benefit; finally, the control of atherogenic dyslipidaemia, with fenofibrate added to a statin, did not modify the composite endpoint (despite a positive effect in the subgroup of patients with high triglycerides and low HDL cholesterol). These rather disappointing results should be interpreted to provide practical guidelines. [less ▲]

Detailed reference viewed: 59 (3 ULg)
Full Text
See detailÀ l'Hôtel des Étrangers, repaire d'une bohème zutique
Saint-Amand, Denis ULg

in Brissette, Pascal; Glinoer, Anthony (Eds.) Bohème sans frontière. Production et internationalisation d'une posture. (2010)

Detailed reference viewed: 88 (8 ULg)